Q: In this task, you are given a text of many news articles seperated by special token "|||||". Your task is to summarize them.
Aspirin may help increase pregnancy chances in women with high inflammation, NIH study finds 
  
 What 
  
 A daily low dose of aspirin may help a subgroup of women, those who have previously lost a pregnancy, to successfully conceive and carry a pregnancy to term, according to an analysis by researchers at the National Institutes of Health. The women who benefited from the aspirin treatment had high levels of C-reactive protein (CRP), a substance in the blood indicating system-wide inflammation, which aspirin is thought to counteract. The study appears in the Journal of Clinical Endocrinology and Metabolism. 
  
 Researchers at NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) analyzed data originally obtained from the Effects of Aspirin in Gestation and Reproduction (EAGeR) trial. The trial sought to determine if daily low-dose aspirin could prevent subsequent pregnancy loss among women who had one or two prior losses. 
  
 For the current study, researchers classified the women into 3 groups: low CRP (below .70 mg per liter of blood), mid CRP (from .70 to 1.95) and high CRP (at or above 1.95). Women within each group received either daily low-dose aspirin or a placebo. In their analysis, researchers found no significant differences in birth rates between those receiving aspirin and those receiving placebo in both the low CRP and mid CRP groups. For the high CRP group, those taking the placebo had the lowest rate of live birth at 44 percent, while those taking daily aspirin had a live-birth rate of 59 percent — a 35-percent increase. Aspirin also appeared to reduce CRP levels in the high CRP group when measured during weeks 8, 20, and 36 of pregnancy. 
  
 The authors concluded that more research is needed to confirm the findings and to examine the potential influence of inflammation in becoming pregnant and maintaining pregnancy. 
  
 Who 
  
 Lindsey A. Sjaarda, Ph.D., staff scientist in the NICHD Division of Intramural and Population Health Research, is available for interviews. 
  
 To arrange an interview, call Robert Bock or Meredith Daly at 301-496-5133 or e-mail nichdpress@mail.nih.gov. 
  
 About the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): NICHD conducts and supports research in the United States and throughout the world on fetal, infant and child development; maternal, child and family health; reproductive biology and population issues; and medical rehabilitation. For more information, visit NICHD’s website. 
  
 About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov. 
  
 NIH…Turning Discovery Into Health® ||||| For some women who are trying to get pregnant, taking a low dose of aspirin daily may boost their chances of having a baby, according to a new analysis. 
  
 The analysis, which looked at women who'd had a prior pregnancy loss and taken part in an earlier study, found that women who benefited from the aspirin regimen had high blood levels of C-reactive protein (CRP), a marker of inflammation in the body. Among these women, those who took a daily aspirin were 31 percent more likely to become pregnant, and 35 percent more likely to carry a pregnancy to term, than those who took a placebo. 
  
 However, it's too soon to officially recommend daily aspirin to prevent pregnancy loss, the researchers said. [5 Interesting Facts About Aspirin] 
  
 Prior to this report, researchers knew that inflammation in the body could contribute to reproductive problems. For example, women with pelvic inflammatory disease or polycystic ovary syndrome — two conditions that involve inflammation — are at increased risk for infertility. But few studies have examined whether lowering levels of inflammation in a woman's body would affect her chances of successfully becoming pregnant and giving birth. 
  
 In the new analysis, the researchers analyzed information from more than 1,200 U.S. women ages 18 to 40 who had previously experienced a miscarriage or stillbirth. The women were randomly assigned to take either a low dose of daily aspirin (81 milligrams) — which is thought to counteract inflammation — or a placebo, for six menstrual cycles while they were trying to become pregnant. If the women became pregnant, they continued taking the pills until 36 weeks of pregnancy. (A full-term pregnancy is 39 to 40 weeks.) 
  
 Then, the researchers divided the women into three groups: those with low, medium and high CRP levels. 
  
 Overall, 55 percent of the women in the study became pregnant and gave birth. 
  
 Among the women with high CRP levels, those who took a daily aspirin had a birth rate of 59 percent, compared with just 44 percent among those who took the placebo. Taking daily aspirin also lowered CRP levels in the women with the highest CRP levels. 
  
 Women with low or medium CRP levels had about the same birth rate, regardless of whether they took aspirin or a placebo, the researchers found. 
  
 In an earlier analysis of this same study, published in 2014, researchers did not find a link between taking aspirin and a reduced risk of pregnancy loss. But for that analysis, the researchers did not look at the level of inflammation in the women's bodies. 
  
 The new findings suggest that "inflammation may significantly harm women's ability to become pregnant," and that taking aspirin prior to conception may reduce this risk, the researchers said. 
  
 In the future, doctors might consider using a screening test for CRP levels to determine whether a woman may benefit from aspirin treatment before and during pregnancy, the researchers said. However, future studies would be needed to examine this, and to determine exactly what the cutoff would be for "high" CRP levels, they said. 
  
 Taking high doses of aspirin (more than 100 milligrams a day) during pregnancy may increase the risk of pregnancy loss, congenital defects and complications with the fetuses' heart, according to the Mayo Clinic. Women should speak with their doctor about taking pain medication during pregnancy. 
  
 The anaysis, conducted by researchers at the Eunice Kennedy Shriver National Institute of Child Health and Human Development, was published online Feb. 3 in the Journal of Clinical Endocrinology and Metabolism. 
  
 Original article on Live Science. ||||| This PDF is available to Subscribers Only 
  
 For full access to this pdf, sign in to an existing account, or purchase an annual subscription. |||||
A:
Inflammation wreaks all sorts of havoc on the human body. One example involves reproduction, because inflammation is behind multiple issues—such as pelvic inflammatory disease and polycystic ovary syndrome—that increase a woman's risk of infertility. So can managing inflammation improve those women's chances of getting pregnant? Researchers at the National Institutes of Health set out to find out, and though they say more research is required to confirm their findings, the early answer appears to be yes, at least in certain women. Reporting in the Journal of Clinical Endocrinology and Metabolism, researchers studied more than 1,200 women between 18 and 40 who'd suffered a miscarriage or stillbirth. They were assigned at random to take either a low dose of aspirin (81mg) every day or a placebo for six menstrual cycles as they tried to conceive; if they became pregnant, they kept taking it through week 36, reports Live Science. Measuring inflammation by looking at a key marker, C-reactive protein (CRP), they found that aspirin lowered inflammation in the women with the highest CRP levels, and their live-birth rate was 59%, compared to 44% of women taking the placebo who had the highest levels—that's a 34% increase. Live Science notes that taking more than 100mg of daily aspirin while pregnant could be harmful. (Could aspirin help prevent Alzheimer's?)